All In MedTech

Device Trial Radar · NCT06672159

Initial Double Sequential External Defibrillation in Out of Hospital Cardiac Arrest

A Randomized Controlled Trial on Early Double External Sequential Defibrillation in Out of Hospital Cardiac Arrest

Last checked: Nov 19, 2026Latest source record: Jul 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 356 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

356

Planned (sponsor's estimate)

Start

Apr 28, 2025

Primary completion

Jun 2028

Study completion Oct 2028

Sponsor

Lead sponsor
St. Olavs HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Norwegian Air Ambulance Foundation
First posted
Nov 4, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Double Sequential External Defibrillation (DSED) represents an alternative treatment of refractory ventricular fibrillation (rVF) in out-of-hospital cardiac arrest (OHCA). The procedure consists of two defibrillators that administer shocks at the same time. Currently, the procedure is not initiated before at least three failed attempts with one defibrillator. This can delay the potential benefits of establishing DSED earlier in the treatment. Studies have shown that early defibrillation is crucial for survival in OHCA patients, and in 2022, a clinical trial showed that survival in patients treated with DSED was higher compared to standard treatment. The effect of initiating OHCA treatment is unknown. The DUALDEFIB trial seeks to investigate if treating OHCA patients with DSED as an initial treatment will increase survival and provide improved neurological outcome.

Conditions

  • Cardiac Arrest
  • Out-Of-Hospital Cardiac Arrest
  • Ventricular Fibrillation

Interventions

  • Two defibrillatorsDevice

    DSED procedure consists of pads placed in anterior-lateral position, and in anterior-posterior position. Defibrillations will be given in rapid sequence, less than a second apart. All other aspects of resuscitation in accordance to existing guidelines.

  • One defibrillatorDevice

    Standard OHCA treatment according to existing guidelines.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of patients that survive to hospital admission.Time frame: 24 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • St Olavs Hospital

    Trondheim, Norway · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.